SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ra7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.40A	1ghmA-4ra7A: 15.3	1ghmA-4ra7A: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 TYR A 720 SER A 737 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-4.1A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.87A	1ghmA-4ra7A: 15.3	1ghmA-4ra7A: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GSF_A_EAAA223_1 (GLUTATHIONE TRANSFERASE A1-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	GLY A 631 LEU A 626 VAL A 634 PHE A 904	None	1.22A	1gsfA-4ra7A: undetectable	1gsfA-4ra7A: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GSF_B_EAAB223_1 (GLUTATHIONE TRANSFERASE A1-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	GLY A 631 LEU A 626 VAL A 634 PHE A 904	None	1.22A	1gsfB-4ra7A: undetectable	1gsfB-4ra7A: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GSF_D_EAAD223_1 (GLUTATHIONE TRANSFERASE A1-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	GLY A 631 LEU A 626 VAL A 634 PHE A 904	None	1.22A	1gsfD-4ra7A: undetectable	1gsfD-4ra7A: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.49A	1i2wA-4ra7A: 15.7	1i2wA-4ra7A: 22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 THR A 876 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.4A)	0.54A	1i2wB-4ra7A: 15.8	1i2wB-4ra7A: 22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PBC_A_BHAA396_0 (P-HYDROXYBENZOATE HYDROXYLASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	GLY A 572 LEU A 669 TYR A 652 LEU A 657 ALA A 574	None	1.26A	1pbcA-4ra7A: undetectable	1pbcA-4ra7A: 22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SGU_B_MK1B2632_2 (POL POLYPROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.83A	1sguB-4ra7A: undetectable	1sguB-4ra7A: 12.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T3R_A_017A1200_1 (PROTEASE RETROPEPSIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.65A	1t3rA-4ra7A: undetectable	1t3rA-4ra7A: 12.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T7I_A_017A200_1 (POL POLYPROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.67A	1t7iA-4ra7A: undetectable	1t7iA-4ra7A: 12.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892 ASP A 895	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.70A	1ymxA-4ra7A: 16.8	1ymxA-4ra7A: 22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.61A	1ymxB-4ra7A: 16.4	1ymxB-4ra7A: 22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AQU_B_DR7B300_2 (HIV-1 PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 11	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.86A	2aquB-4ra7A: undetectable	2aquB-4ra7A: 12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B7Z_B_MK1B200_2 (HIV-1 PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.77A	2b7zB-4ra7A: undetectable	2b7zB-4ra7A: 12.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2D55_C_DVAC2_0 (ACTINOMYCIN D)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	3 / 3	THR A 640 PRO A 830 PRO A 849	None	0.90A	2d55C-4ra7A: undetectable	2d55C-4ra7A: 3.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q2H_B_ACTB501_0 (SECRETION CHAPERONE, PHAGE-DISPLAY DERIVED PEPTIDE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	3 / 3	ARG A 672 SER A 648 TYR A 678	None	1.00A	2q2hA-4ra7A: undetectable 2q2hB-4ra7A: undetectable	2q2hA-4ra7A: 14.89 2q2hB-4ra7A: 14.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R5Q_D_1UND900_2 (PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.90A	2r5qD-4ra7A: undetectable	2r5qD-4ra7A: 12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E23_A_SAMA221_0 (UNCHARACTERIZED PROTEIN RPA2492)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	LEU A 626 TYR A 629 GLY A 924 GLY A 631 SER A 630	None	1.03A	3e23A-4ra7A: undetectable	3e23A-4ra7A: 18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKQ_A_ROCA100_1 (PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.88A	3ekqA-4ra7A: undetectable	3ekqA-4ra7A: 13.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EL9_A_DR7A100_2 (PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.93A	3el9B-4ra7A: undetectable	3el9B-4ra7A: 13.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_B_CHDB200_0 (ILEAL BILE ACID-BINDING PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 5	PRO A 638 VAL A 917 THR A 765 GLY A 762	None	0.77A	3elzB-4ra7A: 0.6	3elzB-4ra7A: 13.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FZG_A_SAMA300_0 (16S RRNA METHYLASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	HIS A 801 SER A 803 GLY A 806 GLY A 799 VAL A 755	None	1.30A	3fzgA-4ra7A: undetectable	3fzgA-4ra7A: 17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.49A	3hlwA-4ra7A: 16.8	3hlwA-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.38A	3hlwB-4ra7A: 17.0	3hlwB-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 ASN A 739 LYS A 890 THR A 891 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.57A	3huoA-4ra7A: 16.8	3huoA-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	LYS A 685 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.62A	3huoB-4ra7A: 16.7	3huoB-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LZV_A_017A200_1 (HIV-1 PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.67A	3lzvA-4ra7A: undetectable	3lzvA-4ra7A: 12.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NVK_I_SAMI228_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	GLY A 937 ALA A 880 ALA A 625 VAL A 940 GLN A 943	None	0.89A	3nvkI-4ra7A: undetectable	3nvkI-4ra7A: 20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NVK_J_SAMJ228_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE NOP5/NOP56 RELATED PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	GLY A 937 ALA A 880 ALA A 625 VAL A 940 GLN A 943	None	0.90A	3nvkF-4ra7A: undetectable 3nvkJ-4ra7A: undetectable	3nvkF-4ra7A: 19.96 3nvkJ-4ra7A: 20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.66A	3ny4A-4ra7A: 16.3	3ny4A-4ra7A: 23.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OF4_B_ACTB313_0 (NITROREDUCTASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	3 / 3	ALA A 624 VAL A 621 GLN A 943	None	0.73A	3of4B-4ra7A: undetectable	3of4B-4ra7A: 19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.58A	3q07A-4ra7A: 16.6	3q07A-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.71A	3q07B-4ra7A: 16.6	3q07B-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.37A	3sh8A-4ra7A: 16.3	3sh8A-4ra7A: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.42A	3sh8B-4ra7A: 16.0	3sh8B-4ra7A: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_B_MIYB2001_1 (TETX2 PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	PHE A 684 GLY A 681 GLY A 746 MET A 778	None NXU A1001 ( 4.0A) None None	0.94A	3v3nB-4ra7A: undetectable	3v3nB-4ra7A: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_C_MIYC2001_1 (TETX2 PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	PHE A 684 GLY A 681 GLY A 746 MET A 778	None NXU A1001 ( 4.0A) None None	0.94A	3v3nC-4ra7A: undetectable	3v3nC-4ra7A: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_A_LDPA501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 6	PHE A 761 ALA A 855 ALA A 861 THR A 860	None	1.02A	4dtzA-4ra7A: undetectable	4dtzA-4ra7A: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 6	PHE A 761 ALA A 855 ALA A 861 THR A 860	None	1.02A	4dtzB-4ra7A: undetectable	4dtzB-4ra7A: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.74A	4euzA-4ra7A: 15.7	4euzA-4ra7A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.53A	4fh2A-4ra7A: 17.2	4fh2A-4ra7A: 23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J4V_D_SVRD301_1 (NUCLEOCAPSID PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 11	GLY A 708 ASN A 719 ARG A 736 ALA A 733 GLN A 744	None	1.19A	4j4vD-4ra7A: undetectable 4j4vE-4ra7A: undetectable	4j4vD-4ra7A: 20.52 4j4vE-4ra7A: 20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MJQ_A_27RA401_1 (DNA POLYMERASE III SUBUNIT BETA)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 5	ARG A 552 TYR A 554 THR A 538 PRO A 555	None	1.33A	4mjqA-4ra7A: undetectable	4mjqA-4ra7A: 23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.35A	4n9kA-4ra7A: 16.2	4n9kA-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.36A	4n9kB-4ra7A: 16.2	4n9kB-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.62A	4pm5A-4ra7A: 16.9	4pm5A-4ra7A: 22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.70A	4pm7A-4ra7A: 17.0	4pm7A-4ra7A: 22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.61A	4pm9A-4ra7A: 16.8	4pm9A-4ra7A: 22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q1X_A_017A101_1 (ASPARTYL PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 11	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.62A	4q1xA-4ra7A: undetectable	4q1xA-4ra7A: 12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QGI_A_ROCA101_1 (PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 11	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.98A	4qgiA-4ra7A: undetectable	4qgiA-4ra7A: 11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 11	SER A 738 THR A 740 GLN A 744 GLY A 726 THR A 727	None	0.94A	4qvyH-4ra7A: undetectable	4qvyH-4ra7A: 20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RVD_A_SAMA502_0 (D-MYCAROSE 3-C-METHYLTRANSFERAS E)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	ILE A 922 GLY A 933 ALA A 880 VAL A 920 ILE A 633	None	1.03A	4rvdA-4ra7A: undetectable	4rvdA-4ra7A: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RVG_A_SAMA503_0 (D-MYCAROSE 3-C-METHYLTRANSFERAS E)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	ILE A 922 GLY A 933 ALA A 880 VAL A 920 ILE A 633	None	1.03A	4rvgA-4ra7A: undetectable	4rvgA-4ra7A: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_B_P06B801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 4	GLY A 762 VAL A 827 PHE A 908 ILE A 821	None	1.17A	4xv2B-4ra7A: undetectable	4xv2B-4ra7A: 19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B6I_A_ADNA302_1 (FLUORINASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 7	ASP A 557 THR A 653 TYR A 652 SER A 561	None	1.27A	5b6iA-4ra7A: undetectable	5b6iA-4ra7A: 21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B6I_B_ADNB302_1 (FLUORINASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 6	ASP A 557 THR A 653 TYR A 652 SER A 561	None	1.26A	5b6iB-4ra7A: undetectable	5b6iB-4ra7A: 21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 11	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.36A	5ghzA-4ra7A: 16.0	5ghzA-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 10	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.37A	5ghzB-4ra7A: 16.1	5ghzB-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IGY_A_ERYA403_0 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	ILE A 922 GLY A 924 ASN A 902 GLU A 623 SER A 651	None	1.09A	5igyA-4ra7A: undetectable	5igyA-4ra7A: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KR1_B_017B101_2 (PROTEASE PR5-DRV)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	GLY A 933 ALA A 934 GLY A 907 ILE A 906	None	0.55A	5kr1B-4ra7A: undetectable	5kr1B-4ra7A: 12.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OJ0_A_9WTA801_0 (PENICILLIN-BINDING PROTEIN 2X)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	SER A 737 ASN A 739 THR A 876 GLY A 892 THR A 893	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	1.03A	5oj0A-4ra7A: 31.1	5oj0A-4ra7A: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_A_SAMA201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	ILE A 532 GLY A 529 THR A 538 LEU A 539 VAL A 564	None	0.93A	5twjA-4ra7A: undetectable	5twjA-4ra7A: 16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VYH_A_FOLA409_0 (S PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	PRO A 797 ALA A 790 GLY A 715 THR A 716 ILE A 712	None	1.34A	5vyhA-4ra7A: undetectable	5vyhA-4ra7A: 22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZWR_A_9KLA402_0 (EST-Y29)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	PHE A 761 ILE A 817 GLY A 692 ALA A 691 LEU A 754	None	1.11A	5zwrA-4ra7A: 13.7	5zwrA-4ra7A: 23.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.63A	6b5yB-4ra7A: 16.3	6b5yB-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.67A	6b5yD-4ra7A: 16.2	6b5yD-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.53A	6b68B-4ra7A: 16.3	6b68B-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.58A	6b68D-4ra7A: 16.2	6b68D-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.54A	6b69A-4ra7A: 15.8 6b69B-4ra7A: 16.1	6b69A-4ra7A: 13.23 6b69B-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.48A	6b69D-4ra7A: 16.0	6b69D-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.55A	6b6aB-4ra7A: 16.4	6b6aB-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.50A	6b6aD-4ra7A: 16.4	6b6aD-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.62A	6b6cA-4ra7A: 16.5	6b6cA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.64A	6b6dA-4ra7A: 16.2	6b6dA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.50A	6b6eA-4ra7A: 16.4	6b6eA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.64A	6b6fA-4ra7A: 16.3	6b6fA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.68A	6b6fA-4ra7A: 16.3	6b6fA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.34A	6c79A-4ra7A: 16.5	6c79A-4ra7A: 12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DH0_A_017A101_0 (PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	GLY A 933 ALA A 934 ILE A 887 GLY A 907 ILE A 906	None	0.56A	6dh0A-4ra7A: undetectable	6dh0A-4ra7A: 10.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DH0_A_017A101_0 (PROTEASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	GLY A 933 ALA A 934 VAL A 872 ILE A 887 GLY A 907	None	0.76A	6dh0A-4ra7A: undetectable	6dh0A-4ra7A: 10.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GTQ_B_ACTB207_0 (DUF1778 DOMAIN-CONTAINING PROTEIN N-ACETYLTRANSFERASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 6	LEU A 742 THR A 688 CYH A 794 GLY A 746	None	1.40A	6gtqB-4ra7A: undetectable 6gtqD-4ra7A: undetectable	6gtqB-4ra7A: 18.89 6gtqD-4ra7A: 7.69

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.40A","1ghmA-4ra7A:15.3","1ghmA-4ra7A:20.39"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;TYR A 720;SER A 737;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-4.1A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.87A","1ghmA-4ra7A:15.3","1ghmA-4ra7A:20.39"],["1GSF_A_EAAA223_1","GLUTATHIONE TRANSFERASE A1-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"GLY A 631;LEU A 626;VAL A 634;PHE A 904","None","1.22A","1gsfA-4ra7A:undetectable","1gsfA-4ra7A:19.18"],["1GSF_B_EAAB223_1","GLUTATHIONE TRANSFERASE A1-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"GLY A 631;LEU A 626;VAL A 634;PHE A 904","None","1.22A","1gsfB-4ra7A:undetectable","1gsfB-4ra7A:19.18"],["1GSF_D_EAAD223_1","GLUTATHIONE TRANSFERASE A1-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"GLY A 631;LEU A 626;VAL A 634;PHE A 904","None","1.22A","1gsfD-4ra7A:undetectable","1gsfD-4ra7A:19.18"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.49A","1i2wA-4ra7A:15.7","1i2wA-4ra7A:22.88"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;SER A 737;ASN A 739;THR A 876;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.4A)","0.54A","1i2wB-4ra7A:15.8","1i2wB-4ra7A:22.88"],["1PBC_A_BHAA396_0","P-HYDROXYBENZOATE HYDROXYLASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 572;LEU A 669;TYR A 652;LEU A 657;ALA A 574","None","1.26A","1pbcA-4ra7A:undetectable","1pbcA-4ra7A:22.41"],["1SGU_B_MK1B2632_2","POL POLYPROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.83A","1sguB-4ra7A:undetectable","1sguB-4ra7A:12.08"],["1T3R_A_017A1200_1","PROTEASE RETROPEPSIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.65A","1t3rA-4ra7A:undetectable","1t3rA-4ra7A:12.95"],["1T7I_A_017A200_1","POL POLYPROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.67A","1t7iA-4ra7A:undetectable","1t7iA-4ra7A:12.95"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892;ASP A 895","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.70A","1ymxA-4ra7A:16.8","1ymxA-4ra7A:22.91"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.61A","1ymxB-4ra7A:16.4","1ymxB-4ra7A:22.91"],["2AQU_B_DR7B300_2","HIV-1 PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.86A","2aquB-4ra7A:undetectable","2aquB-4ra7A:12.64"],["2B7Z_B_MK1B200_2","HIV-1 PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.77A","2b7zB-4ra7A:undetectable","2b7zB-4ra7A:12.67"],["2D55_C_DVAC2_0","ACTINOMYCIN D","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",3,"THR A 640;PRO A 830;PRO A 849","None","0.90A","2d55C-4ra7A:undetectable","2d55C-4ra7A:3.10"],["2Q2H_B_ACTB501_0","SECRETION CHAPERONE, PHAGE-DISPLAY DERIVED PEPTIDE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",3,"ARG A 672;SER A 648;TYR A 678","None","1.00A","2q2hA-4ra7A:undetectable;2q2hB-4ra7A:undetectable","2q2hA-4ra7A:14.89;2q2hB-4ra7A:14.89"],["2R5Q_D_1UND900_2","PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.90A","2r5qD-4ra7A:undetectable","2r5qD-4ra7A:12.73"],["3E23_A_SAMA221_0","UNCHARACTERIZED PROTEIN RPA2492","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"LEU A 626;TYR A 629;GLY A 924;GLY A 631;SER A 630","None","1.03A","3e23A-4ra7A:undetectable","3e23A-4ra7A:18.28"],["3EKQ_A_ROCA100_1","PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.88A","3ekqA-4ra7A:undetectable","3ekqA-4ra7A:13.18"],["3EL9_A_DR7A100_2","PROTEASE;PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.93A","3el9B-4ra7A:undetectable","3el9B-4ra7A:13.18"],["3ELZ_B_CHDB200_0","ILEAL BILE ACID-BINDING PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"PRO A 638;VAL A 917;THR A 765;GLY A 762","None","0.77A","3elzB-4ra7A:0.6","3elzB-4ra7A:13.84"],["3FZG_A_SAMA300_0","16S RRNA METHYLASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"HIS A 801;SER A 803;GLY A 806;GLY A 799;VAL A 755","None","1.30A","3fzgA-4ra7A:undetectable","3fzgA-4ra7A:17.53"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.49A","3hlwA-4ra7A:16.8","3hlwA-4ra7A:22.69"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.38A","3hlwB-4ra7A:17.0","3hlwB-4ra7A:22.69"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;ASN A 739;LYS A 890;THR A 891;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.57A","3huoA-4ra7A:16.8","3huoA-4ra7A:22.69"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"LYS A 685;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.62A","3huoB-4ra7A:16.7","3huoB-4ra7A:22.69"],["3LZV_A_017A200_1","HIV-1 PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.67A","3lzvA-4ra7A:undetectable","3lzvA-4ra7A:12.95"],["3NVK_I_SAMI228_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 937;ALA A 880;ALA A 625;VAL A 940;GLN A 943","None","0.89A","3nvkI-4ra7A:undetectable","3nvkI-4ra7A:20.04"],["3NVK_J_SAMJ228_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE;NOP5\/NOP56 RELATED PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 937;ALA A 880;ALA A 625;VAL A 940;GLN A 943","None","0.90A","3nvkF-4ra7A:undetectable;3nvkJ-4ra7A:undetectable","3nvkF-4ra7A:19.96;3nvkJ-4ra7A:20.04"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.66A","3ny4A-4ra7A:16.3","3ny4A-4ra7A:23.80"],["3OF4_B_ACTB313_0","NITROREDUCTASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",3,"ALA A 624;VAL A 621;GLN A 943","None","0.73A","3of4B-4ra7A:undetectable","3of4B-4ra7A:19.14"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.58A","3q07A-4ra7A:16.6","3q07A-4ra7A:22.69"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.71A","3q07B-4ra7A:16.6","3q07B-4ra7A:22.69"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.37A","3sh8A-4ra7A:16.3","3sh8A-4ra7A:20.79"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.42A","3sh8B-4ra7A:16.0","3sh8B-4ra7A:20.79"],["3V3N_B_MIYB2001_1","TETX2 PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"PHE A 684;GLY A 681;GLY A 746;MET A 778","None;NXU A1001 ( 4.0A);None;None","0.94A","3v3nB-4ra7A:undetectable","3v3nB-4ra7A:20.73"],["3V3N_C_MIYC2001_1","TETX2 PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"PHE A 684;GLY A 681;GLY A 746;MET A 778","None;NXU A1001 ( 4.0A);None;None","0.94A","3v3nC-4ra7A:undetectable","3v3nC-4ra7A:20.73"],["4DTZ_A_LDPA501_1","CYTOCHROME P450 BM3 VARIANT 8C8","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"PHE A 761;ALA A 855;ALA A 861;THR A 860","None","1.02A","4dtzA-4ra7A:undetectable","4dtzA-4ra7A:20.82"],["4DTZ_B_LDPB501_1","CYTOCHROME P450 BM3 VARIANT 8C8","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"PHE A 761;ALA A 855;ALA A 861;THR A 860","None","1.02A","4dtzB-4ra7A:undetectable","4dtzB-4ra7A:20.82"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.74A","4euzA-4ra7A:15.7","4euzA-4ra7A:21.83"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.53A","4fh2A-4ra7A:17.2","4fh2A-4ra7A:23.74"],["4J4V_D_SVRD301_1","NUCLEOCAPSID PROTEIN;NUCLEOCAPSID PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 708;ASN A 719;ARG A 736;ALA A 733;GLN A 744","None","1.19A","4j4vD-4ra7A:undetectable;4j4vE-4ra7A:undetectable","4j4vD-4ra7A:20.52;4j4vE-4ra7A:20.52"],["4MJQ_A_27RA401_1","DNA POLYMERASE III SUBUNIT BETA","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"ARG A 552;TYR A 554;THR A 538;PRO A 555","None","1.33A","4mjqA-4ra7A:undetectable","4mjqA-4ra7A:23.19"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.35A","4n9kA-4ra7A:16.2","4n9kA-4ra7A:21.01"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.36A","4n9kB-4ra7A:16.2","4n9kB-4ra7A:21.01"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.62A","4pm5A-4ra7A:16.9","4pm5A-4ra7A:22.47"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.70A","4pm7A-4ra7A:17.0","4pm7A-4ra7A:22.39"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.61A","4pm9A-4ra7A:16.8","4pm9A-4ra7A:22.37"],["4Q1X_A_017A101_1","ASPARTYL PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.62A","4q1xA-4ra7A:undetectable","4q1xA-4ra7A:12.73"],["4QGI_A_ROCA101_1","PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.98A","4qgiA-4ra7A:undetectable","4qgiA-4ra7A:11.76"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"SER A 738;THR A 740;GLN A 744;GLY A 726;THR A 727","None","0.94A","4qvyH-4ra7A:undetectable","4qvyH-4ra7A:20.44"],["4RVD_A_SAMA502_0","D-MYCAROSE 3-C-METHYLTRANSFERASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"ILE A 922;GLY A 933;ALA A 880;VAL A 920;ILE A 633","None","1.03A","4rvdA-4ra7A:undetectable","4rvdA-4ra7A:25.24"],["4RVG_A_SAMA503_0","D-MYCAROSE 3-C-METHYLTRANSFERASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"ILE A 922;GLY A 933;ALA A 880;VAL A 920;ILE A 633","None","1.03A","4rvgA-4ra7A:undetectable","4rvgA-4ra7A:25.24"],["4XV2_B_P06B801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"GLY A 762;VAL A 827;PHE A 908;ILE A 821","None","1.17A","4xv2B-4ra7A:undetectable","4xv2B-4ra7A:19.35"],["5B6I_A_ADNA302_1","FLUORINASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"ASP A 557;THR A 653;TYR A 652;SER A 561","None","1.27A","5b6iA-4ra7A:undetectable","5b6iA-4ra7A:21.80"],["5B6I_B_ADNB302_1","FLUORINASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"ASP A 557;THR A 653;TYR A 652;SER A 561","None","1.26A","5b6iB-4ra7A:undetectable","5b6iB-4ra7A:21.80"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.36A","5ghzA-4ra7A:16.0","5ghzA-4ra7A:21.01"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.37A","5ghzB-4ra7A:16.1","5ghzB-4ra7A:21.01"],["5IGY_A_ERYA403_0","MACROLIDE 2'-PHOSPHOTRANSFERASE II","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"ILE A 922;GLY A 924;ASN A 902;GLU A 623;SER A 651","None","1.09A","5igyA-4ra7A:undetectable","5igyA-4ra7A:20.79"],["5KR1_B_017B101_2","PROTEASE PR5-DRV","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"GLY A 933;ALA A 934;GLY A 907;ILE A 906","None","0.55A","5kr1B-4ra7A:undetectable","5kr1B-4ra7A:12.05"],["5OJ0_A_9WTA801_0","PENICILLIN-BINDING PROTEIN 2X","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"SER A 737;ASN A 739;THR A 876;GLY A 892;THR A 893","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","1.03A","5oj0A-4ra7A:31.1","5oj0A-4ra7A:24.10"],["5TWJ_A_SAMA201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"ILE A 532;GLY A 529;THR A 538;LEU A 539;VAL A 564","None","0.93A","5twjA-4ra7A:undetectable","5twjA-4ra7A:16.78"],["5VYH_A_FOLA409_0","S PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"PRO A 797;ALA A 790;GLY A 715;THR A 716;ILE A 712","None","1.34A","5vyhA-4ra7A:undetectable","5vyhA-4ra7A:22.20"],["5ZWR_A_9KLA402_0","EST-Y29","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"PHE A 761;ILE A 817;GLY A 692;ALA A 691;LEU A 754","None","1.11A","5zwrA-4ra7A:13.7","5zwrA-4ra7A:23.45"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.63A","6b5yB-4ra7A:16.3","6b5yB-4ra7A:13.23"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.67A","6b5yD-4ra7A:16.2","6b5yD-4ra7A:13.23"],["6B68_B_9F2B301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.53A","6b68B-4ra7A:16.3","6b68B-4ra7A:13.23"],["6B68_D_9F2D400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.58A","6b68D-4ra7A:16.2","6b68D-4ra7A:13.23"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.54A","6b69A-4ra7A:15.8;6b69B-4ra7A:16.1","6b69A-4ra7A:13.23;6b69B-4ra7A:13.23"],["6B69_D_9F2D301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.48A","6b69D-4ra7A:16.0","6b69D-4ra7A:13.23"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.55A","6b6aB-4ra7A:16.4","6b6aB-4ra7A:13.23"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.50A","6b6aD-4ra7A:16.4","6b6aD-4ra7A:13.23"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.62A","6b6cA-4ra7A:16.5","6b6cA-4ra7A:13.23"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.64A","6b6dA-4ra7A:16.2","6b6dA-4ra7A:13.23"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.50A","6b6eA-4ra7A:16.4","6b6eA-4ra7A:13.23"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.64A","6b6fA-4ra7A:16.3","6b6fA-4ra7A:13.23"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.68A","6b6fA-4ra7A:16.3","6b6fA-4ra7A:13.23"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.34A","6c79A-4ra7A:16.5","6c79A-4ra7A:12.22"],["6DH0_A_017A101_0","PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;ILE A 887;GLY A 907;ILE A 906","None","0.56A","6dh0A-4ra7A:undetectable","6dh0A-4ra7A:10.99"],["6DH0_A_017A101_0","PROTEASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"GLY A 933;ALA A 934;VAL A 872;ILE A 887;GLY A 907","None","0.76A","6dh0A-4ra7A:undetectable","6dh0A-4ra7A:10.99"],["6GTQ_B_ACTB207_0","DUF1778 DOMAIN-CONTAINING PROTEIN;N-ACETYLTRANSFERASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"LEU A 742;THR A 688;CYH A 794;GLY A 746","None","1.40A","6gtqB-4ra7A:undetectable;6gtqD-4ra7A:undetectable","6gtqB-4ra7A:18.89;6gtqD-4ra7A:7.69"]]